122 related articles for article (PubMed ID: 18072099)
1. Foxy methoxy: a new drug of abuse.
Smolinske SC; Rastogi R; Schenkel S
J Med Toxicol; 2005 Dec; 1(1):22-5. PubMed ID: 18072099
[TBL] [Abstract][Full Text] [Related]
2. Rhabdomyolysis after ingestion of "foxy," a hallucinogenic tryptamine derivative.
Alatrash G; Majhail NS; Pile JC
Mayo Clin Proc; 2006 Apr; 81(4):550-1. PubMed ID: 16610577
[TBL] [Abstract][Full Text] [Related]
3. A foxy intoxication.
Wilson JM; McGeorge F; Smolinske S; Meatherall R
Forensic Sci Int; 2005 Feb; 148(1):31-6. PubMed ID: 15607587
[TBL] [Abstract][Full Text] [Related]
4. A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
Tanaka E; Kamata T; Katagi M; Tsuchihashi H; Honda K
Forensic Sci Int; 2006 Nov; 163(1-2):152-4. PubMed ID: 16406422
[TBL] [Abstract][Full Text] [Related]
5. Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
Williams MT; Herring NR; Schaefer TL; Skelton MR; Campbell NG; Lipton JW; McCrea AE; Vorhees CV
Neuropsychopharmacology; 2007 Jun; 32(6):1404-20. PubMed ID: 17047665
[TBL] [Abstract][Full Text] [Related]
6. Ketamine-like effects after recreational use of methoxetamine.
Hofer KE; Grager B; Müller DM; Rauber-Lüthy C; Kupferschmidt H; Rentsch KM; Ceschi A
Ann Emerg Med; 2012 Jul; 60(1):97-9. PubMed ID: 22237166
[TBL] [Abstract][Full Text] [Related]
7. An examination of the effects of 5-Methoxy-n, n-di(ISO)propyltryptamine hydrochloride (Foxy) on cognitive development in rats.
Compton DM; Selinger MC; Testa EK; Larkins KD
Psychol Rep; 2006 Jun; 98(3):651-61. PubMed ID: 16933659
[TBL] [Abstract][Full Text] [Related]
8. Foxy, a designer tryptamine hallucinogen.
Meatherall R; Sharma P
J Anal Toxicol; 2003; 27(5):313-7. PubMed ID: 12908946
[TBL] [Abstract][Full Text] [Related]
9. Prolonged delusional state triggered by repeated ingestion of aromatic liquid in a past 5-methoxy-N, N-diisopropyltryptamine abuser.
Fuse-Nagase Y; Nishikawa T
Addict Sci Clin Pract; 2013 Apr; 8(1):9. PubMed ID: 23577618
[TBL] [Abstract][Full Text] [Related]
10. 5-methoxy-N,N-di(iso)propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence.
Compton DM; Dietrich KL; Selinger MC; Testa EK
Physiol Behav; 2011 May; 103(2):203-9. PubMed ID: 21295050
[TBL] [Abstract][Full Text] [Related]
11. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N
Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management.
Scharman EJ; Erdman AR; Cobaugh DJ; Olson KR; Woolf AD; Caravati EM; Chyka PA; Booze LL; Manoguerra AS; Nelson LS; Christianson G; Troutman WG;
Clin Toxicol (Phila); 2007; 45(7):737-52. PubMed ID: 18058301
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.
Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH
Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
Kamata T; Katagi M; Kamata HT; Miki A; Shima N; Zaitsu K; Nishikawa M; Tanaka E; Honda K; Tsuchihashi H
Drug Metab Dispos; 2006 Feb; 34(2):281-7. PubMed ID: 16280455
[TBL] [Abstract][Full Text] [Related]
15. New drugs of abuse update: Foxy Methoxy.
Muller AA
J Emerg Nurs; 2004 Oct; 30(5):507-8. PubMed ID: 15452541
[No Abstract] [Full Text] [Related]
16. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
Woolf AD; Erdman AR; Nelson LS; Caravati EM; Cobaugh DJ; Booze LL; Wax PM; Manoguerra AS; Scharman EJ; Olson KR; Chyka PA; Christianson G; Troutman WG
Clin Toxicol (Phila); 2007; 45(3):203-33. PubMed ID: 17453872
[TBL] [Abstract][Full Text] [Related]
17. The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats.
Noworyta-Sokołowska K; Górska AM; Gołembiowska K
Pharmacol Rep; 2018 Oct; 70(5):890-895. PubMed ID: 30096487
[TBL] [Abstract][Full Text] [Related]
18. Unusual presentation of a patient with GBL withdrawal: a case report.
Kashyap GL; Patel AG
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S32-4. PubMed ID: 21894099
[TBL] [Abstract][Full Text] [Related]
19. Accidental ecstasy poisoning in a toddler.
Melian AM; Burillo-Putze G; Campo CG; Padron AG; Ramos CO
Pediatr Emerg Care; 2004 Aug; 20(8):534-5. PubMed ID: 15295251
[TBL] [Abstract][Full Text] [Related]
20. New drugs of abuse in North America.
Haroz R; Greenberg MI
Clin Lab Med; 2006 Mar; 26(1):147-64, ix. PubMed ID: 16567229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
